| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $947.1M | — | +7.2% |
| Gross Profit | $555.8M | — | +5.7% |
| R&D Expense | $51.3M | — | +10.6% |
| SG&A Expense | $258.3M | — | +6.4% |
| Interest Expense | $17.0M | — | +2.1% |
| Pre-tax Income | $209.7M | — | +3.8% |
| Income Tax | $40.2M | — | +4.8% |
| Net Income | $169.5M | — | +3.6% |
| EPS (Basic) | $8.35 | — | +6.5% |
| EPS (Diluted) | $8.33 | — | +6.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $708.2M | -9.0% | +10.9% |
| Inventory | $404.8M | +4.5% | +12.8% |
| Current Assets | $1.33B | -2.3% | +14.3% |
| Total Assets | $3.67B | -1.2% | +13.4% |
| Current Liabilities | $1.11B | -7.5% | -3.6% |
| Long-term Debt | $2.16B | +3.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $139.8M | — | -28.1% |
| Capital Expenditures | $17.4M | — | +0.9% |
| Investing Cash Flow | -$31.3M | — | -353.9% |
| Financing Cash Flow | -$114.3M | — | +37.9% |
| Free Cash Flow | $122.4M | — | -30.9% |
| +14.3% |
| Total Liabilities | $3.71B | -0.7% | +8.6% |
| Stockholders' Equity | -$41.9M | -77.2% | +77.0% |